Considered Words on Risk | GenomeWeb

Considered Words on Risk

Premium

In May 2000, a month before researchers at the Human Genome Project and Celera Genomics announced their completed draft sequences of the human genome, Gil Omenn published a hunch in the Annual Review of Public Health. On his mind was the idea that while sequencing the human genome would "surely stimulate a golden age for the public health sciences," as he wrote then, it would also generate a slew of ethical enigmas.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.

Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.

Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.

A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.